BloodSafe eLearning Australia: Release of video on IV Iron administration in Primary Care

Iron deficiency is a common cause of anaemia. In Australia current clinical management recommends use of oral iron as first-line therapy for most patients presenting with IDA. However, oral iron therapy may be of limited benefit to some people, including those with impaired intestinal iron absorption or who experience GI side effects that reduce adherence. Oral iron therapy may also be inappropriate in cases of severe IDA, in which rapid iron repletion is required to prevent physiological decompensation or the need for blood transfusion.

Intravenous iron administration may be an alternative in these patients. To assist General Practitioners BloodSafe eLearning Australia (BEA) has developed and released a video on IV Iron administration in primary care. You can find the video in the videos page of their resources section.

The BEA program develops eLearning courses and resources that influence knowledge and provide consistent educational messages to a variety of health care workers and professionals. It is supported by all Australian Governments, the National Blood Authority (NBA), the Australian Red Cross Blood Service (Blood Service) and the Australian and New Zealand Society of Blood Transfusion (ANZSBT).

CLICK HERE for Procedure for Administration of Ferinject® (Ferric Carboxymaltose) – NSLHD.